$39.99
▼ $0.49 (-1.2%)
RIGL
Rigel Pharmaceuticals, Inc. - Common Stock
Health Care
Investor Score
68B-
Moderate rating
Based on 7 of 7 weighted categories, computed from real, live financial data only.
69
Technical
83
Fundamental
74
Growth
55
Fair Value
62
News
63
Quality
54
Risk
Want the full breakdown — DCF fair value, technical indicators, news sentiment, and an AI-written narrative explaining this score?
View the full analysis (Hebrew) ←All raw data comes from real commercial financial data providers. This page is for educational purposes only and is not investment advice.